scholarly journals A Rare Case of a Woman Presenting with Axillary Silicone Lymphadenopathy Accompanied by Extracapsular Siliconoma and Thickened Capsule after an Implant-based Augmentation Mammaplasty

2021 ◽  
Vol 7 (2) ◽  
Author(s):  
Kim JH

According to a review of literatures, silicone-induced lymphadenopathy occurs in association with rupture or silicone leakage. It has been reported to cause inflammation, neuropathy or systemic disorder. It should therefore be detected both correctly and promptly. The author experienced a rare case of a 38-year-old woman presenting with axillary silicone lymphadenopathy due to rupture of a silicone gel-filled breast implant. The patient received primary augmentation mammaplasty using a breast implant at other hospital; the current case highlights the importance of an ultrasoundassisted diagnosis of silicone lymphadenopathy before reoperation in a patient with rupture.

Medicina ◽  
2021 ◽  
Vol 57 (12) ◽  
pp. 1370
Author(s):  
Sanghyuk Han ◽  
Robert Kim ◽  
Tae Seob Kim ◽  
Jung Heum Park ◽  
Seung Soo Kim ◽  
...  

Background and objectives We conducted this preliminary retrospective study to assess the short-term safety of silicone gel-filled breast implants (SGBIs) that are commercially available in Korean women. Materials and methods The current retrospective, observational study was conducted in a total of 2612 patients (n =2612) who underwent augmentation mammaplasty using breast implants at our hospitals between 1 January, 2017 and 31 August 2021. Results Overall, there were a total of 248 cases (9.49%) of postoperative complications; these include 112 cases of early seroma, 52 cases of shape deformation, 32 cases of CC, 12 cases of early hematoma, 12 cases of rupture, 12 cases of infection, 12 cases of stretch deformities with skin excess and 4 cases of rippling. Overall complication-free survival of the breast implant was estimated at 1564.32 ± 75.52 days (95% CI 1416.39–1712.32). Then, the Motiva Ergonomix™SilkSurface showed the longest survival (1528.00 ± 157.92 days [95% CI 1218.48–1837.56]), followed by the BellaGelÒSmoothFine (1458.4 ± 65.76 days [95% CI 1329.56–1587.28]), the SebbinÒ Sublimity (1322.00 ± 51.20 days [95% CI 1221.64–1422.32]), the BellaGelÒ Smooth (1138.72 ± 161.28 days [95% CI 822.6–1454.84), the MentorÒ MemoryGel™ Xtra (698.4 ± 52.64 days [95% CI 595.28–801.52]) and the NatrelleÒ INSPIRA™ (380.00 ± 170.88 days [95% CI 45.04–714.96]) in the decreasing order. On subgroup analysis, both the Motiva ErgonomixTM and MentorÒ MemoryGel™ Xtra showed no postoperative complications. However, the BellaGelÒSmoothFine, SebbinÒ Sublimity and BellaGelÒ Smooth showed incidences of 8.87%, 4.84% and 1.61%, respectively. A subgroup analysis also showed differences in incidences of postoperative complications between microtextured and smooth breast implants (15.18% vs. 16.67%). Conclusions In conclusion, our results indicate that diverse types of an SGBI are commercially available and their safety profile varies according to the manufacturer. Plastic surgeons should consider the safety profile of each device in selecting the optimal types of the device for Korean women who are in need of an implant-based augmentation mammaplasty. However, this warrants a single-surgeon, single-center studywith long periods of follow-up.


2019 ◽  
Vol 6 (2) ◽  
pp. 43 ◽  
Author(s):  
Harold J. Brandon ◽  
Larry S. Nichter ◽  
Dwight D. Back

The IDEAL IMPLANT® Structured Breast Implant is a dual lumen saline-filled implant with capsular contracture and deflation/rupture rates much lower than single-lumen silicone gel-filled implants. To better understand the implant’s mechanical properties and to provide a potential explanation for these eight-year clinical results, a novel approach to compressive load testing was employed. Multi-dimensional strains and tangent moduli, metrics describing the shape stability of the total implant, were derived from the experimental load and platen spacing data. The IDEAL IMPLANT was found to have projection, diametric, and areal strains that were generally less than silicone gel implants, and tangent moduli that were generally greater than silicone gel implants. Despite having a relatively inviscid saline fill, the IDEAL IMPLANT was found to be more shape stable compared to gel implants, which implies potentially less interaction with the capsule wall when the implant is subjected to compressive loads. Under compressive loads, the shape stability of a higher cross-link density, cohesive gel implant was unexpectedly found to be similar to or the same as a gel implant. In localized diametric compression testing, the IDEAL IMPLANT was found to have a palpability similar to a gel implant, but softer than a cohesive gel implant.


2011 ◽  
Vol 1 (1) ◽  
pp. 43-45
Author(s):  
Abdulhakeem O. Althaqafi ◽  
Atif W. Qubbany ◽  
Asim K. Saleh ◽  
Muntasir M. Abdelaziz

Although tuberculosis-related to sudden death is recognize, complication of tuberculosis is rarely reported in the literature of the Middle East. A rare case of tuberculosis-related to sudden death was presented in a 28-year-old Saudi woman who was admitted to our hospital for pulmonary tuberculosis. Although anti-tuberculosis medication was started, she died suddenly; 7 days later, most probably due to a massive hemoptysis. The literature on tuberculosis-related to sudden death in relation to the current case have been reviewed and discussed in this report.


1993 ◽  
Vol 10 (2) ◽  
pp. 89-93
Author(s):  
Howard A. Tobin

This article summarizes the regulatory actions of the Food & Drug Administration as related to gel-filled silicone breast implants. It also relates the actions to the influences of outside forces such as press coverage, congressional investigations, and consumer activism.


2002 ◽  
Vol 48 (1) ◽  
pp. 92-101 ◽  
Author(s):  
Ralph R. Cook ◽  
Steven J. Bowlin ◽  
James M. Curtis ◽  
Susan J. Hoshaw ◽  
Patti J. Klein ◽  
...  

2019 ◽  
Vol 26 (2) ◽  
pp. 247-251
Author(s):  
Marco Gardani ◽  
Elisa Bellini ◽  
Gabriele Villani ◽  
Nicola Orsi ◽  
Dante Palli

2020 ◽  
Vol 11 (4) ◽  
pp. 202-206
Author(s):  
Catherine Watson Genna

Breast surgery increases the risk for difficulties with milk production and breastfeeding. Research on lactation outcomes of breast augmentation with implants is reassuring, but reveals a significant risk of low milk production that varies with the type of surgery and position of the implants. Understanding the potential effects of breast implants on breastfeeding can help lactation professionals optimize outcomes for families with a history of augmentation mammaplasty.


Sign in / Sign up

Export Citation Format

Share Document